• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者肠道微生物群组成与冲动控制障碍之间的关联

Associations Between Gut Microbiota Composition and Impulse Control Disorders in Parkinson's Disease.

作者信息

Lin Sheng-Hsuan, Lin Ru-Jen, Chu Chia-Ling, Chen Yan-Lin, Fu Shih-Chen

机构信息

Institute of Statistics, National Yang Ming Chiao Tung University, Hsinchu 300093, Taiwan.

Institute of Data Science and Engineering, National Yang Ming Chiao Tung University, Hsinchu 300093, Taiwan.

出版信息

Int J Mol Sci. 2025 Jun 26;26(13):6146. doi: 10.3390/ijms26136146.

DOI:10.3390/ijms26136146
PMID:40649930
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12249796/
Abstract

Impulse control disorders (ICDs) are a debilitating non-motor symptom of Parkinson's disease (PD), often associated with dopaminergic therapy. However, their occurrence in some patients but not others suggests additional biological mechanisms, including the gut microbiome. In this study, we analyzed 191 PD patients (14 with ICDs, 177 without) using 16S rRNA gene sequencing to explore the association between gut microbiota and ICDs. No significant differences were observed in alpha or beta diversity between groups, but several bacterial taxa showed differential abundances. Notably, and were enriched in ICD patients. Functional pathway analysis revealed differences in metabolic pathways, including enrichment of and in the ICD group. These findings suggest that specific gut microbial taxa and their associated metabolic functions may contribute to ICDs in PD, highlighting a potential non-dopaminergic mechanism and opening new avenues for microbiome-targeted intervention.

摘要

冲动控制障碍(ICDs)是帕金森病(PD)一种使人衰弱的非运动症状,常与多巴胺能治疗相关。然而,它们在一些患者中出现而在另一些患者中未出现,这表明存在其他生物学机制,包括肠道微生物群。在本研究中,我们使用16S rRNA基因测序分析了191例PD患者(14例有ICDs,177例无ICDs),以探讨肠道微生物群与ICDs之间的关联。两组之间在α或β多样性方面未观察到显著差异,但几个细菌分类群显示出丰度差异。值得注意的是,[具体细菌分类群1]和[具体细菌分类群2]在ICD患者中富集。功能通路分析揭示了代谢通路的差异,包括[具体代谢通路1]和[具体代谢通路2]在ICD组中的富集。这些发现表明,特定的肠道微生物分类群及其相关的代谢功能可能导致PD患者出现ICDs,突出了一种潜在的非多巴胺能机制,并为以微生物群为靶点的干预开辟了新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb0/12249796/682209516580/ijms-26-06146-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb0/12249796/bb2f35847c8f/ijms-26-06146-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb0/12249796/132e03358e80/ijms-26-06146-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb0/12249796/3d24313e1527/ijms-26-06146-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb0/12249796/682209516580/ijms-26-06146-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb0/12249796/bb2f35847c8f/ijms-26-06146-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb0/12249796/132e03358e80/ijms-26-06146-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb0/12249796/3d24313e1527/ijms-26-06146-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb0/12249796/682209516580/ijms-26-06146-g004.jpg

相似文献

1
Associations Between Gut Microbiota Composition and Impulse Control Disorders in Parkinson's Disease.帕金森病患者肠道微生物群组成与冲动控制障碍之间的关联
Int J Mol Sci. 2025 Jun 26;26(13):6146. doi: 10.3390/ijms26136146.
2
Anxiety-related gut microbiota alterations in Parkinson's disease: distinct associations compared to healthy individuals.帕金森病中与焦虑相关的肠道微生物群改变:与健康个体相比的不同关联。
Front Cell Infect Microbiol. 2025 Jun 18;15:1594152. doi: 10.3389/fcimb.2025.1594152. eCollection 2025.
3
Multiple perinatal characteristics affect the association between maternal diabetes status and early neonatal gut microbiota.多种围产期特征会影响母亲糖尿病状态与早期新生儿肠道微生物群之间的关联。
mSphere. 2025 Jun 25;10(6):e0091424. doi: 10.1128/msphere.00914-24. Epub 2025 May 16.
4
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation.肠道生物标志物、微生物群组成以及炎症性肠病的遗传易感性作为帕金森病表现的预测指标。
J Parkinsons Dis. 2025 May 7:1877718X251328567. doi: 10.1177/1877718X251328567.
5
Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review.神经退行性疾病(帕金森病和阿尔茨海默病)患者与健康对照者的肠道微生物组成:系统评价。
Nutrients. 2023 Oct 13;15(20):4365. doi: 10.3390/nu15204365.
6
Alterations of fecal microbiota and plasma metabolome in patients with Parkinson's disease with rapid eye movement sleep disorder.伴有快速眼动睡眠障碍的帕金森病患者粪便微生物群和血浆代谢组的改变
mSphere. 2025 Jun 25;10(6):e0059024. doi: 10.1128/msphere.00590-24. Epub 2025 May 9.
7
Integrated multi-omics analysis reveals the functional signature of microbes and metabolomics in pre-diabetes individuals.综合多组学分析揭示了糖尿病前期个体中微生物和代谢组学的功能特征。
Microbiol Spectr. 2025 Jul;13(7):e0145924. doi: 10.1128/spectrum.01459-24. Epub 2025 Jun 9.
8
Pharmaco-psychiatry and gut microbiome: a systematic review of effects of psychotropic drugs for bipolar disorder.药物精神病学与肠道微生物群:双相情感障碍精神药物疗效的系统评价
Microbiology (Reading). 2025 Jun;171(6). doi: 10.1099/mic.0.001568.
9
Will gut, oral, and vaginal microbiota influence the outcome of FET or be influenced by FET? A pilot study.肠道、口腔和阴道微生物群会影响冻融胚胎移植(FET)的结果还是会受到FET的影响?一项初步研究。
mBio. 2025 Jul 9;16(7):e0050925. doi: 10.1128/mbio.00509-25. Epub 2025 Jun 17.
10
Changes in the gut microbiota and derived fecal metabolites may play a role in tacrolimus-induced diabetes in mice.肠道微生物群和粪便衍生代谢产物的变化可能在小鼠他克莫司诱导的糖尿病中起作用。
Future Microbiol. 2025 Feb;20(3):237-246. doi: 10.1080/17460913.2024.2444761. Epub 2024 Dec 22.

本文引用的文献

1
Faecal microbiota composition and impulsivity in a cohort of older adults with metabolic syndrome.代谢综合征老年患者队列的粪便微生物组成与冲动性。
Sci Rep. 2024 Nov 14;14(1):28075. doi: 10.1038/s41598-024-78527-8.
2
Gut Microbiome in Impulsively Violent Female Convicts.冲动暴力女性罪犯的肠道微生物群
Neuropsychobiology. 2025;84(1):1-14. doi: 10.1159/000542220. Epub 2024 Nov 1.
3
The correlation between gut microbiota and both neurotransmitters and mental disorders: A narrative review.肠道微生物群与神经递质和精神障碍的相关性:叙述性综述。
Medicine (Baltimore). 2024 Feb 2;103(5):e37114. doi: 10.1097/MD.0000000000037114.
4
Gut microbiota dysbiosis contributes to α-synuclein-related pathology associated with C/EBPβ/AEP signaling activation in a mouse model of Parkinson's disease.在帕金森病小鼠模型中,肠道微生物群失调会导致与C/EBPβ/AEP信号激活相关的α-突触核蛋白相关病理变化。
Neural Regen Res. 2024 Sep 1;19(9):2081-2088. doi: 10.4103/1673-5374.391191. Epub 2024 Jan 12.
5
Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies.帕金森病与肠道微生物群:从临床到机制和治疗研究。
Transl Neurodegener. 2023 Dec 15;12(1):59. doi: 10.1186/s40035-023-00392-8.
6
Gut microbiome dysbiosis across early Parkinson's disease, REM sleep behavior disorder and their first-degree relatives.肠道微生物组失调与早期帕金森病、快速眼动睡眠行为障碍及其一级亲属。
Nat Commun. 2023 May 2;14(1):2501. doi: 10.1038/s41467-023-38248-4.
7
Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis.帕金森病中的肠道微生物群失调:一项系统评价和汇总分析。
Eur J Neurol. 2023 Nov;30(11):3581-3594. doi: 10.1111/ene.15671. Epub 2023 Jan 18.
8
The effect of microbiome composition on impulsive and violent behavior: A systematic review.微生物群组成对冲动和暴力行为的影响:一项系统综述。
Behav Brain Res. 2023 Feb 25;440:114266. doi: 10.1016/j.bbr.2022.114266. Epub 2022 Dec 20.
9
Gut bacterial profiles in Parkinson's disease: A systematic review.帕金森病的肠道细菌特征:系统评价。
CNS Neurosci Ther. 2023 Jan;29(1):140-157. doi: 10.1111/cns.13990. Epub 2022 Oct 25.
10
The gut microbiota-bile acid axis links the positive association between chronic insomnia and cardiometabolic diseases.肠道微生物群-胆汁酸轴将慢性失眠与代谢性心血管疾病之间的正相关联系起来。
Nat Commun. 2022 May 30;13(1):3002. doi: 10.1038/s41467-022-30712-x.